ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

An Elaborate New Linker System Significantly Enhances the Efficacy of an HER2-Antibody-Drug Conjugate against Refractory HER2-Positive Cancers.

Seol Hwa Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.